Study of Carfilzomib and Vorinostat for Relapsed or Refractory Lymphoma

NCT01276717 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

20

Enrollment

OTHER

Sponsor class

Conditions

Lymphoma

Interventions

DRUG: Drug: Carfilzomib
DRUG: Vorinostat

Sponsor

University of Rochester

Collaborators

[object Object]